by Strados Labs | Jul 23, 2024 | Press Releases
Strados Labs, a digital health company focused on improving the lives of patients with respiratory diseases, announced today the successful completion of a recent study of its technology in pediatric asthma, which took place at Ann & Robert H. Lurie Children’s...
by Strados Labs | Jun 6, 2024 | Press Releases
Strados Labs is excited to announce its participation in a groundbreaking project led by the Digital Medicine Society (DiMe), a global non-profit dedicated to driving scientific progress and broad acceptance in digital medicine. The project, Building the Business Case...
by Strados Labs | Apr 8, 2024 | Events
Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18. Hosted by the American Thoracic Society, the Respiratory Innovation Summit...
by Strados Labs | Feb 27, 2024 | Blog, Blog - Clinical Trial Focus
24-hour cough frequency has traditionally been recognized as the ‘gold standard’ primary endpoint for indications such as refractory chronic cough, chronic bronchitis, and IPF-related cough. While frequency is undoubtedly a valuable metric to measure for cough, there...
by Strados Labs | Jan 29, 2024 | Blog, Blog - Clinical Trial Focus
In December 2023, the FDA published its final release of “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations” a pivotal step in formalizing regulatory standards and guidance for remote data collection in clinical trials. As the...
